Cylex公司推出新型细胞学检测方法

 
一种免疫系统功能检测的细胞学分析方法，只要使用一滴血液就能够测定移植患者的免疫功能。该检测允许医生对患者使用个体化的免疫抑制治疗方法，以防止器官排斥反应，同时避免感染。

ImmuKnow是Cylex公司(Columbia, MD, USA)的产品，当前在许多美国医院和诊所配备在患者治疗方案之中。它是一种标准化的细胞学检测方法，能够十分方便的在实验室中进行，能够快速而准确的得到检测结果。通过最佳化的治疗，该检测能够帮助医生降低治疗成本，减少药物副作用，提高患者的远期生活质量。

 
Cellular Assay Guides Post-Transplant Therapy
 
A cellular assay of immune system function using a single drop of blood measures the vitality of a transplant patient’s immune status. The assay allows doctors to tailor individual transplant patient immunosuppressant regimens to prevent organ rejection while avoiding infection.

ImmuKnow, a Cylex (Columbia, MD, USA) product, is currently incorporated into patient protocols at many U.S. hospitals and clinics. It is a standardized cellular assay, easily performed in the lab, with quick and accurate results. By optimizing therapy, the assay helps physicians lower the cost of treatment, reduce side-effects of drugs, and enhance patients’ prospects for long-term quality of life.